CTRI/2026/01/0101982尚未招募不适用
Understanding the group of homoeopathic remedies with emphasis on interpersonal relationships assessed with The Network of Relationships Inventory - Relationship Quality Version (NRI-RQV) among the End Stage Renal Disease (ESRD) patients.
Dr. M. L. Dhawale Memorial Homoeopathic Institute1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2026年2月2日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 23
- 试验地点
- 1
- 主要终点
- Understanding group of Homoeopathic Remedies along with quality of interpersonal relationships assessed by Network of Relationships Inventory-Relationship Quality Version among End Stage Renal Disease Patients.
研究概览
简要总结
TITLE- Understanding the group of homoeopathic remedies with emphasis on interpersonal relationships assessed with The Network of Relationships Inventory - Relationship Quality Version (NRI-RQV) among the End Stage Renal Disease (ESRD) patients.
PRIMARY OBJECTIVES -To identify and assess patterns of positive and negative expressions of interpersonal relationships in ESRD patients by using NRI-RQV.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •a)Cases of ESRD in which homoeopathic remedies are prescribed.
- •b) Cases from both sexes.
- •c) Age 18 years and above.
- •d) Patients who are able to understand questions from NRI-RQV.
排除标准
- •a) Patients having insight of Grade II and below it.
- •b) Patients who are orphans.
- •c) Patients with inconsistent follow ups.
结局指标
主要结局
Understanding group of Homoeopathic Remedies along with quality of interpersonal relationships assessed by Network of Relationships Inventory-Relationship Quality Version among End Stage Renal Disease Patients.
时间窗: 4 weeks
次要结局
未报告次要终点
研究者
Dr Keshav Bhagwat Nakate
Dr.M.L.Dhawale Memorial Homoeopathic Institute
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
香胡当芎行调胶囊治疗原发性痛经评价其有效性和安全性的试验CTR20212083216
已完成
不适用
盐酸帕洛诺司琼软胶囊人体生物等效性研究CTR2025057218
进行中（未招募）
2 期
异功散颗粒Ⅱa 期临床试验CTR2025462060
进行中（未招募）
不适用
评价三七通舒胶囊肠溶微丸胶囊与原胶囊是否等效的试验活血化瘀，活络通脉，改善脑梗塞、脑缺血功能障碍，恢复缺血性脑代谢异常，抗血小板聚集，防止血栓形成，改善微循环，降低全血粘度，增强颈动脉血流量，用于心脑血管栓塞性病症，主治中风、半身不遂、口舌歪斜、言语蹇涩、偏身麻木。CTR2014001424
进行中（未招募）
1 期
健康受试者单次和多次口服 HRS-3095 片的安全性、耐受性、药代动力学、药效学和食物影响以及 HRS-3095 对 CYP3A4 代谢酶影响的 I 期临床试验慢性自发性荨麻疹CTR2025421866